Supernormal conduction in the anomalous bundles of the Wolff-Parkinson- White syndrome: An overlooked electrophysiologic property with potential clinical implications

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 12, Issue 3, 2007, Pages 181-191

  Chiale, Pablo A ^a,b,c   Albino, Ernesto ^b   Garro, Hugo A ^b,c   Selva, Horacio ^b   Levi, Raúl J ^b   Sánchez, Rubén A ^b,c   Elizari, Marcelo V ^b   Álvarez, Carlos B ^a,c  

^a PONTIFICIA UNIVERSIDAD CATÓLICA ARGENTINA   (Argentina)

^b HOSPITAL RAMOS MEJÍA   (Argentina)

^c Instituto Sacre Coeur   (Argentina)

Author keywords

Anterograde supernormal conduction; AV accessory pathways; Isoproterenol; Refractory periods; Retrograde supernormal conduction

Indexed keywords

ADULT; ARTICLE; CASE REPORT; FEMALE; HEART ELECTROPHYSIOLOGY; HEART MUSCLE REFRACTORY PERIOD; HIS BUNDLE; HUMAN; MALE; PRIORITY JOURNAL; WOLFF PARKINSON WHITE SYNDROME;

ADULT; ATRIAL FIBRILLATION; ELECTROPHYSIOLOGY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; SYNCOPE; VENTRICULAR FIBRILLATION; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 34548188521     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/1074248407304183     Document Type: Article

References (22)

1. Wellens Hjj, Durrer D. Relation between refractory period of the accessory pathway and ventricular frequency during atrial fibrillation in patients with the Wolff-ParkinsonWhite syndrome. Am J Cardiol. 1974 ; 34: 777-782.
2. Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med. 1979 ; 301: 1080-1085.
3. Attoyan C., Haissaguerre M., Dartigues JF, Le Metayer P., Warin JF, Clementy J. La fibrillation ventriculaire dans le syndrome de Wolff-Parkinson-White. Facteurs prédictifs. Arch Mal Coeur Vaiss. 1994 ; 87: 889-896.
4. Wellens Hjj. El síndrome de Wolff-Parkinson-White en individuos asintomáticos. In: Elizari MV, Chiale PA, eds. Arritmias Cardíacas. Fundamentos Celulares y Moleculares, Diagnóstico y Tratamiento. Buenos Aires, Argentina: Editorial Médica Panamericana ; 2003: 511-515.
5. Wellens Hjj. Wolff-Parkinson-White syndrome. Part I. Mod Concepts Cardiovasc Dis. 1983 ; 52: 53-78.
6. Levy S., Bronstet JP, Clementy J. Syndrome de WolffParkinson-White. Correlation entre l'exploration electrophysiologíque et l'effet de l'epreuve d'effort sur l'aspect electrocardiographique de pre-excitation. Arch Mal Coeur Vaiss. 1979 ; 72: 634-642.
7. Wellens Hjj, Bar FW, Gorgels, Vanagt EJ Use of ajmaline in patients with the Wolff-Parkinson-White syndrome to disclose short refractory period of their accessory pathway. Am J Cardiol. 1980 ; 45: 130-133.
8. Wellens Hjj, Braat SH, Brugada P., Gorgels AP, Bar FW Use of procainamide in patients with the Wolff-Parkinson-White syndrome and a short refractory period of the accessory pathway. Am J Cardiol. 1982 ; 50: 1087-1089.
9. Przybylski J., Chiale PA, Halpern MS, Nau GJ, Elizari MV, Rosenbaum MB Unmasking of ventricular preexcitation by vagal stimulation or isoproterenol administration. Circulation. 1980 ; 61: 1030-1037.
10. Przybylski J., Chiale PA, Sánchez RA, et al. Supernormal conduction in the accessory pathway of patients with overt or concealed preexcitation. J Am Coll Cardiol. 1987 ; 9: 1269-1278.
11. Chang MS, Miles WM, Prystowsky EN Supernormal conduction in accessory atrioventricular connections. Am J Cardiol. 1987 ; 59: 852-856.
12. Levi RJ, Salerno JA, Nau GJ, Elizari MV, Rosenbaum MB A reappraisal of supernormal conduction. In: Rosenbaum MB, Elizari MV, eds. Frontiers of Cardiac Electrophysiology. The Hague, Netherlands: Martinus Nijhoff ; 1983: 427-456.
13. Suguta M., Nogami A., Naito S., et al. Retrograde supernormal conduction in concealed accessory atrioventricular pathway following catheter ablation. J Cardiovasc Electrophysiol. 1997 ; 8: 1291-1295.
14. Rosenbaum MB, Levi RJ, Elizari MV, Vetulli HM, Sánchez RA Supernormal excitability and conduction. Cardiol Clin. 1983 ; 1: 75-92.
15. McHenry PL, Knoebel S., Fisch C. The Wolff-ParkinsonWhite (WPW) syndrome with supernormal conduction through the anomalous bypass. Circulation. 1966 ; 34: 734-739.
16. Chen PS, Prystowsky E. Role of concealed and supernormal conductions during atrial fibrillation in the preexcitation syndrome. Am J Cardiol. 1991 ; 68: 1329-1334.
17. Chiale PA, Contreras L. El síndrome de Wolff-Parkinson-White y las taquiarritmias asociadas. In: Elizari MV, Chiale PA, eds. Arritmias Cardíacas. Fundamentos Celulares y Moleculares, Diagnóstico y Tratamiento. Buenos Aires, Argentina: Editorial Médica Panamericana ; 2003: 471-495.
18. Aldariz AE, Levi RJ, Acunzo RS, Halpern MS Conducción 1:1 en fase supernormal. Rev Arg Cardiol. 1998 ; 66: 203-211.
19. Basso C., Corrado D., Rossi L., Thiene G. Ventricular preexcitacion in children and young adults: atrial myocarditis as a possible trigger of sudden death. Circulation. 2001 ; 103: 269-275.
20. Furlanello F., Vecchiet L., Bettini R., et al. Arritmias en Atletas. In: Cosin J, Bayés de Luna A, García Civera R, Cabades A, eds. Diagnóstico y Tratamiento de las Arritmias Cardíacas. Barcelona, Spain: Doyma ; 1988: 230-234.
21. Spear JF, Moore EN Supernormal excitability and conduction in the His-Purkinje system of the dog. Circ Res. 1974 ; 35: 782-792.
22. Childers RW, Merideth J., Moe GK Supernormality in Bachman's bundle. Circ Res. 1968 ; 22: 363-379.